Post by
Noteable on Apr 19, 2022 2:03pm
Gilead sees 33% revenues will come from oncology by 2030
https://www.fiercepharma.com/pharma/gilead-maps-out-its-oncology-ambitions-seeing-33-revenue-coming-oncology-drugs-2030
https://investors.gilead.com/static-files/332d0c81-fa18-44fa-82d3-babf96ca12d0
Comment by
fox7mf on Apr 19, 2022 2:17pm
I can't wait for the day that Noteable posts about an Onc partnership, or an Onc buyout or at least rumors surrounding the aforementioned.